Risky Benefits

Ushering in a New Era for Telemedicine - Risky Benefits S4, Ep. #9

FBMC Benefits Management, Inc. Season 4 Episode 9

People have complex medical situations in life and the wrong decision can lead to disaster. With MediOrbis, a physician-founded digital health company, it’s reassuring to know that providers are readily available to help get patients with complex conditions through difficult times with expert, innovative telehealth services. 

Listen as Risky Benefits podcast guest, Dr. Jonathan Wiesen, CMO and MediOrbis founder, discusses how MediOrbis fills the need for comprehensive care through integrated specialty telehealth, telehealth utilization and trends, and medical case studies. MediOrbis provides access to top-tier physicians and innovation in clinical services to help deliver the best care to patients in a time and cost-effective manner.

MORE ABOUT OUR GUESTS:
Jonantha Wiesen,
MD
CMO and MediOrbis Founder
MediOrbis.com

Dr. Jonathan Wiesen is a pulmonary and critical care physician, teacher, researcher and medical technology pioneer with a passion for clinical medicine and telehealth innovation.

Graduating from the Albert Einstein College of Medicine with distinction in research, he completed his training in internal medicine as well as pulmonary and critical care at the Cleveland Clinic - earning an advanced teaching degree and several teaching and research awards.

As founder and chief medical officer of MediOrbis, he led the development of ground-breaking clinical programs for monitoring and managing chronic medical conditions and providing integrated medical specialty services. He also piloted the development of a global network of top physicians to deliver the company’s telemedicine services worldwide.

Currently, Dr. Wiesen is a pulmonary specialist at Ben Gurion University’s Soroka Medical Center, where he directs the Cardio-Pulmonary Exercise Program. For many years, he has advised and assessed medical technology companies and served on the board of several companies, specializing in clinical assessment and due diligence.



To listen in and subscribe to more episodes, visit our website: fbmc.com/podcast.